---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-007467"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:22:13.217619+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Heart Test Labs enters $15M equity purchase agreement with Lincoln Park Capital

## Summary
- Company may sell up to $15M of common stock to Lincoln Park over 36 months at its discretion.
- Issued 100,000 shares as initial commitment; additional 62,500 shares due upon $2M proceeds.
- Daily purchase limits: up to 50,000 shares normally, rising to 200,000 if stock above $2.50.
- Lincoln Park barred from shorting; proceeds used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0000950170-23-007467
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017023007467/0000950170-23-007467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017023007467/hscs-20230310.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-007467
- JSON: https://secwatch.observer/filing/0000950170-23-007467.json
- Plain text: https://secwatch.observer/filing/0000950170-23-007467.txt

## Key facts
- Material Agreements
  HeartSciences Inc. entered into purchase agreement with Lincoln Park Capital Fund, LLC valued at up to $15.0 million (effective 2023-03-10).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: Lincoln Park Capital Fund, LLC
  - Value: up to $15.0 million
  - Effective: 2023-03-10
  source text: On March 10, 2023, Heart Test Laboratories, Inc. (the "Company") entered into a purchase agreement and a registration rights agreement with an institutional investor, Lincoln Park Capital Fund, LLC ("Lincoln Park"), an Illinois limited liability company, providing for the purchase of up to $15.0 million worth of the Company's common stock, par value $0.001 per share, over the thirty-six month term of the purchase agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468492/000095017023007467/0000950170-23-007467-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.